Strategy
MSTR
NVIDIA
NVDA
Meta Platforms
META
Oracle
ORCL
Amazon
AMZN
US Stock MarketDetailed Quotes
IPSC Century Therapeutics
- 0.694
- -0.009-1.21%
Close Feb 26 16:00 ET
- 0.713
- +0.019+2.78%
Post 20:01 ET
58.97MMarket Cap-0.38P/E (TTM)
0.730High0.670Low557.28KVolume0.701Open0.702Pre Close385.22KTurnover1.44%Turnover RatioLossP/E (Static)85.03MShares5.51052wk High0.30P/B26.91MFloat Cap0.67052wk Low--Dividend TTM38.81MShs Float32.899Historical High--Div YieldTTM8.55%Amplitude0.670Historical Low0.691Avg Price1Lot Size
About Century Therapeutics Company
Century Therapeutics, Inc. engages in the development of off-the-shelf cell therapies to advance the course of cancer care. It focuses on harnessing the power of adult stem cells to develop curative allogeneic cell therapies for cancer. The company was founded by Marcela Maus and Hiromitsu Nakauchi in 2018 and is headquartered in Philadelphia, PA.
Company Profile
SymbolIPSC
Company NameCentury Therapeutics
Listing DateJun 18, 2021
Issue Price20.00
Founded2018
CEOMr. Brent Pfeiffenberger, M.B.A.,PhD
MarketNASDAQ
Employees165
Fiscal Year Ends12-31
Address38th Street, 25 North,11th Floor
CityPhiladelphia
ProvincePennsylvania
CountryUnited States of America
Zip Code19104
Phone1-267-817-5790
Websitehttp://www.centurytx.com
Company Executives
- Name
- Position
- Salary
- Brent Pfeiffenberger, M.B.A.,PhD
- Director, President and Chief Executive Officer
- 3.24M
- Dr. Gregory Russotti, PhD
- Chief Technology and Manufacturing Officer
- 2.59M
- Dr. Adrienne Farid, PhD
- Chief Operations Officer
- 1.71M
- Dr. Morgan Conn, PhD
- Chief Financial Officer
- --
- Joseph Jimenez
- Chairman of the Board
- 197.40K
- Dr. Hyam I. Levitsky,M.D.
- President of Research and Development
- --
- Dr. Carlo Rizzuto, PhD
- Independent Director
- 168.40K
- Cynthia M. Butitta
- Independent Director
- 170.65K
- Dr. Alessandro Riva, M.D.
- Independent Director
- 161.90K
- Daphne E. Quimi
- Independent Director
- 169.65K
- Timothy P. Walbert
- Independent Director
- 159.40K
- Dr. Kimberly L. Blackwell, M.D.
- Independent Director
- 165.90K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.